Spinal Kinetics surpassed 50,000 implantations of its M6© artificial cervical and lumbar discs. The systems launched internationally in 2006 and 2010, respectively.
The company is preparing to submit its FDA Premarket Approval application for the treatment of 1-level cervical degenerative disc disease within 2017; enrollment is complete in the Investigational Device Exemption study.
Earlier this month, Simplify Medical closed a Series B financing, gaining $21.0MM to support its own ongoing U.S. pivotal clinical trials of the Simplify cervical disc.
Sources: Spinal Kinetics, Inc.; ORTHOWORLD Inc.
Spinal Kinetics surpassed 50,000 implantations of its M6© artificial cervical and lumbar discs. The systems launched internationally in 2006 and 2010, respectively.
The company is preparing to submit its FDA Premarket Approval application for the treatment of 1-level cervical degenerative disc disease within 2017; enrollment is complete in the...
Spinal Kinetics surpassed 50,000 implantations of its M6© artificial cervical and lumbar discs. The systems launched internationally in 2006 and 2010, respectively.
The company is preparing to submit its FDA Premarket Approval application for the treatment of 1-level cervical degenerative disc disease within 2017; enrollment is complete in the Investigational Device Exemption study.
Earlier this month, Simplify Medical closed a Series B financing, gaining $21.0MM to support its own ongoing U.S. pivotal clinical trials of the Simplify cervical disc.
Sources: Spinal Kinetics, Inc.; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





